Hydroxyzine Pamoate Capsule
FDA Label NDC 0555-0323

21 label sections · Submitted to the FDA by Teva Pharmaceuticals Usa, Inc. · Indications, Dosage, Usage, and Precautions

Structured Product Label

The following Structured Product Label (SPL) was submitted to the FDA by Teva Pharmaceuticals Usa, Inc. for the product Hydroxyzine Pamoate (NDC 0555-0323). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.

This specific version of the label includes detailed information regarding description, clinical pharmacology, indications and usage, contraindications, nursing mothers, precautions, qt prolongation/torsade de pointes (tdp), acute generalized exanthematous pustulosis (agep), and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.

* Please review the disclaimer below.